Medicines
The medicines sector is characterised by a few large pharmaceutical companies and a large number of SME biotech companies.
Medicines
|Experts
|Funding Opportunities
|Case Studies
|Events
|News
|Perspective
|Programmes

Support for companies of all sizes is provided by the Health Team across the sector but particularly linked with the manufacturing of pharmaceuticals and advanced therapeutics. Members of the Health Team are closely aligned with the Medicines Manufacturing Industry Partnership and the Bioindustry Association.
Innovate UK KTN also organises the Medicines Manufacturing Challenge Community. Its core goal is to accelerate the outcomes from the medicines manufacturing ISCF Challenge which has seen £146m invested in different projects, including the Medicines Manufacturing Innovation Centre and Advanced Therapy Treatment Centres.
Related Opportunities
Flexible, agile, scalable and sustainable medicines manufacturing
Opens: 26/09/2023 Closes: 22/11/2023
UK registered organisations can apply for a share of up to £5m for development and implementation of technologies for medicines development and manufacture.
More Information
Canada-UK: Biomanufacturing of Biologics and Advanced Therapies
Opens: 26/06/2023 Closes: 17/10/2023
UK registered organisations can apply for a share of up to £3.5m to collaborate with Canadian SMEs on joint R&D to innovate in biomanufacturing biologics and advanced therapies.
More Information
Biomedical Catalyst 2023 Round 2: Industry-led R&D
Opens: 20/09/2023 Closes: 08/11/2023
UK registered SMEs can apply for a share of up to £20 million to develop innovative solutions to health and healthcare challenges.
More Information
Related Events and Recordings
Programmes related to Medicines

Biomedical Catalyst
Helps transform innovative ideas into commercially viable businesses.

Medimap: End-to-end medicines supply chain map
Medimap is a new interactive reference tool for the UK medicines sector, mapping and categorising over 3,000 sites of organisations engaged in or supporting the end-to-end supply chain for medicines.

Medicines Manufacturing Challenge Community
A now-completed programme that supported manufacturers of medicines in order to grow the UK economy – replaced by the Medicines Manufacturing programme.